After-Hours Movers 7/7: AMGN, RT, ALKS, SHLM Higher; NEXM, XNPT,...
NexMed, Inc. (Nasdaq: NEXM) 64.1% LOWER; announced the mutual decision with Novartis (NYSE: NVS) to terminate the licensing agreement for NM100060, a topically-applied treatment for onychomycosis, commonly known as nail fungus.
NexMed entered into the exclusive, worldwide agreement with Novartis in September 2005, under which Novartis assumed all clinical development, regulatory, manufacturing and commercialization responsibilities for NM100060. Click here for the full report.
Amgen (Nasdaq: AMGN) 13.6% HIGHER; announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus...
Related itemsBone drug zoledronic acid may help prevent spread of...
(European Society for Medical Oncology) A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to...
After-Hours Movers 4/26: NEXM, DAIO, SOA, DVAX, MSPD...
NexMed, Inc. (NASDAQ: NEXM) 52% HIGHER; announced that the U.S. FDA has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for...
Morning Movers 8/4: BNVI, LF, NPO, ANPI, LOOK, PRGX...
Bionovo, Inc. (Nasdaq: BNVI) 93.8% HIGHER; today announced positive results from the Phase 1B clinical trial of Bezielle (formerly BZL101), their lead drug candidate for advanced breast...
Canon Pixma MX700 Office All-On-One Inkjet Printer...
With this networkable PIXMA MX700 All-In-One Office Printer, you'll be able to print photos right from compatible memory cards, selecting and enhancing images on the 1.8" color LCD display or...
Panasonic KP150BK Vertical Electric Pencil Sharpener,...
Vertical Electric Pencil Sharpener
|
|
Post new comment